千红制药
(002550)
| 流通市值：63.51亿 | | | 总市值：85.23亿 |
| 流通股本：9.54亿 | | | 总股本：12.80亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 758,365,706.37 | 358,078,398.61 | 1,571,276,512.22 | 1,215,015,041.44 |
| 营业总成本 | 610,318,487.25 | 265,121,901.26 | 1,260,212,744.09 | 918,885,764.41 |
| 其他经营收益 | | | | |
| 营业利润 | 167,929,554.24 | 102,730,876.29 | 455,631,141.11 | 438,145,315.92 |
| 利润总额 | 167,333,178.5 | 102,799,988.74 | 450,181,945.86 | 437,798,686.06 |
| 净利润 | 142,882,581.49 | 84,497,588.87 | 373,254,947.94 | 368,133,628.6 |
| 每股收益 | | | | |
| 其他综合收益 | -142,698.11 | -1,441,250.69 | 1,869,290.37 | 397,763.3 |
| 综合收益总额 | 142,739,883.38 | 83,056,338.18 | 375,124,238.31 | 368,531,391.9 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,998,820,267.73 | 2,028,720,806.38 | 1,909,727,729.2 | 1,937,455,509.21 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,129,526,996.72 | 1,203,145,443.94 | 1,178,445,247.29 | 1,078,032,976.5 |
| 资产总计 | 3,128,347,264.45 | 3,231,866,250.32 | 3,088,172,976.49 | 3,015,488,485.71 |
| 流动负债: | | | | |
| 流动负债合计 | 299,299,693.28 | 278,061,295.18 | 225,520,207.63 | 163,707,947.23 |
| 非流动负债: | | | | |
| 非流动负债合计 | 102,421,311.1 | 101,754,740.27 | 96,433,892.17 | 92,154,508.2 |
| 负债合计 | 401,721,004.38 | 379,816,035.45 | 321,954,099.8 | 255,862,455.43 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,738,250,111.12 | 2,854,288,442.66 | 2,767,899,632.16 | 2,750,858,850.38 |
| 股东权益合计 | 2,726,626,260.07 | 2,852,050,214.87 | 2,766,218,876.69 | 2,759,626,030.28 |
| 负债和股东权益合计 | 3,128,347,264.45 | 3,231,866,250.32 | 3,088,172,976.49 | 3,015,488,485.71 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 866,705,948.39 | 452,528,076.72 | 1,735,369,559.38 | 1,306,790,650.77 |
| 经营活动现金流出小计 | 688,417,270.71 | 314,268,879.15 | 1,374,008,106.26 | 1,015,443,917.05 |
| 经营活动产生的现金流量净额 | 178,288,677.68 | 138,259,197.57 | 361,361,453.12 | 291,346,733.72 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 874,748,168.84 | 442,861,502.03 | 346,844,940.79 | 1,276,176,156.46 |
| 投资活动现金流出小计 | 1,067,076,446.46 | 436,069,394.87 | 509,186,059.83 | 1,417,678,290.07 |
| 投资活动产生的现金流量净额 | -192,328,277.62 | 6,792,107.16 | -162,341,119.04 | -141,502,133.61 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 76,126,174.5 | 46,126,375 | 32,757,480 | 24,500,000 |
| 筹资活动现金流出小计 | 189,207,241.67 | - | 170,434,116.81 | 170,929,352.81 |
| 筹资活动产生的现金流量净额 | -113,081,067.17 | 46,126,375 | -137,676,636.81 | -146,429,352.81 |
| 汇率变动对现金及现金等价物的影响 | -6,158,312.92 | -1,915,895.88 | -13,051,061.63 | -4,075,986.45 |
| 现金及现金等价物净增加额 | -133,278,980.03 | 189,261,783.85 | 48,292,635.64 | -660,739.15 |
| 期末现金及现金等价物余额 | 354,959,055.62 | 677,499,819.5 | 488,238,035.65 | 439,284,660.86 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -133,278,980.03 | - | 48,292,635.64 | - |
最新报告期：2026-08-13| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东海证券 | 杜永宏 | 0.27 | 0.30 | 0.33 | 2026-08-13 |